Secukinumab (anti-IL-17A)
Secukinumab (anti-IL-17A) (Cosentyx, AIN457) is a human IgG1κ monoclonal antibody that binds to the protein interleukin (IL)-17A, and is applied for the treatment of psoriasis, ankylosing spondylitis, and psoriatic arthritis. MW=147.9 kDa.
| Trivial name | Cosentyx, AIN457 |
| Catalog Number | A2025 |
| CAS# | 1229022-83-6 |
| Size | 1mg*5 |
| Supplier Page | http://www.selleckchem.com/products/secukinumab.html |